ArticleJournal of medicinal chemistry2016

Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast Cancer.

Rui Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.